Inhibition of Immune Cell Subsets Is Differentially Affected By Dasatinib Dosage in Patients with Chronic Phase CML

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
JournalBlood
Volume136
DOIs
Publication statusPublished - 5 Nov 2020

Cite this